Medical
On the journey from pill to platform
For AstraZeneca’s Alex Bedenkov, investing more in post-pandemic medical capabilities is just the start of a far more profound organisation-wide transformation
More Medical Articles
Medical
From insight to action in medical affairs
Physicians’ increasingly digital-first consumption of disease state education offers pharma a way to understand their needs more deeply and so find better ways to serve them
Medical
Redefining the role of the MSL in a changed world
MSLs will need to respond to the growing demands being placed on them in the new normal by adopting new approaches, capabilities and skill sets
Access and Evidence
Bringing innovation to rare disease patients in Europe
Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.
Access and Evidence
#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021
To help raise awareness of rare disease, Reuters Events, Biogen and EU40 have collaborated to launch the #Icare4rare campaign to give prominence to Rare Disease Week 2021
Medical
COVID-19: A data challenge and a catalyst for new insights
The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D
Access and Evidence
Survey results: Accelerating digital transformation during COVID-19
View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
Medical
Paying for cell and gene therapy - Is the future already here?
Multiple novel payment models for CGT are in development but an open and collaborative approach among all healthcare stakeholders is needed if the significant legal and practical barriers are to be overcome
Medical
The age of the digital opinion leader
Key opinion leaders who evolve into the digital sphere to become digital opinion leaders will gain more reach and influence
Medical
The key to digital innovation: The human touch
Takeda is building on strong stakeholder relationships it has nurtured patiently over time to co-create solutions during COVID-19